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Reserve capacityProtein thiolation by glutathione is a reversible and regulated post-translational modiﬁcation that is
increased in response to oxidants and nitric oxide. Because many mitochondrial enzymes contain critical
thiol residues, it has been hypothesized that thiolation reactions regulate cell metabolism and survival.
However, it has been difﬁcult to differentiate the biological effects due to protein thiolation from other
oxidative protein modiﬁcations. In this study, we used diamide to titrate protein glutathiolation and
examined its impact on glycolysis, mitochondrial function, and cell death in rat aortic smooth muscle cells.
Treatment of cells with diamide increased protein glutathiolation in a concentration-dependent manner and
had comparably little effect on protein–protein disulﬁde formation. Diamide increased mitochondrial proton
leak and decreased ATP-linked mitochondrial oxygen consumption and cellular bioenergetic reserve
capacity. Concentrations of diamide above 200 μM promoted acute bioenergetic failure and caused cell death,
whereas lower concentrations of diamide led to a prolonged increase in glycolytic ﬂux and were not
associated with loss of cell viability. Depletion of glutathione using buthionine sulfoximine had no effect on
basal protein thiolation or cellular bioenergetics but decreased diamide-induced protein glutathiolation and
sensitized the cells to bioenergetic dysfunction and death. The effects of diamide on cell metabolism and
viability were fully reversible upon addition of dithiothreitol. These data suggest that protein thiolation
modulates key metabolic processes in both the mitochondria and cytosol.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The formation of mixed disulﬁdes with protein thiols (protein
thiolation) is increased in cells and tissues under conditions of
oxidative stress. In particular, the most abundant low molecular
weight thiol in the cell, glutathione (GSH), readily forms adducts with
cysteinyl protein thiols under many pathological conditions [1–4].
Protein glutathiolation (or glutathionylation) is readily reversible and
has been shown to be regulated by a number of enzymes including
glutaredoxin [5–8], sulﬁredoxin [9,10], protein disulﬁde isomerase
(PDI) [11,12], and glutathione-S-transferase pi (GSTP) [13,14]. Thell; PSSG, protein–glutathione;
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ll rights reserved.abundance of glutathiolated proteins also varies depending on the cell
compartment. It has been estimated that up to 50% of the glutathione
in the endoplasmic reticulum is protein-bound [15], and that, overall,
nearly 3% of all proteins remain bound to glutathione under basal
conditions [16–18]. The functional signiﬁcance of protein thiolation
and glutathiolation, however, is not clear. At low levels and under the
control of redox regulatory enzymes, it is thought to play a role in cell
signaling, but effects on cellular metabolism have not been examined.
It has also been suggested to be a protective mechanism that prevents
deleterious or irreversible protein modiﬁcations under conditions of
oxidative stress [19].
We hypothesized that bioenergetic systems in the cell are
particularly susceptible to protein thiolation for a number of reasons.
For example, mitochondria have a high concentration of both
glutathione and protein thiols, which act in part as protection against
oxidant stress [20]. In addition, solvent-exposed cysteine residues are
present in the active sites of many mitochondrial dehydrogenase
enzymes and are involved in coordinating the structures of enzymes
involved in electron transfer for oxidative phosphorylation. For
example, alpha-ketoglutarate dehydrogenase [21], isocitrate dehy-
drogenase [22], and mitochondrial aldehyde dehydrogenase [23] are
inhibited by glutathiolation, and electron transport chain complexes I
[24,25], II [26], and V [27] can also be modiﬁed by glutathione. Key
regulatory proteins in the glycolytic pathway have also been shown to
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particular, glyceraldehyde-3-phosphate dehydrogenase [28,29] and
aldose reductase [30,31] have been shown to be inhibited by
glutathiolation, which may redirect glucose ﬂux to other pathways
such as the pentose shunt pathway. Therefore, there is a strong
rationale for studying the effect of protein thiolation on whole-cell
bioenergetic function.
Oxidants such as hydrogen peroxide [21,32,33], nitric oxide (NO)
[27,34], and peroxynitrite [2,35] catalyze the formation of protein–
glutathione (PSSG) adducts. However, some of these reactive species
also promote other oxidative modiﬁcations (e.g., protein sulfenic,
sulﬁnic, and sulfonic acids [36,37]) and bind to divalentmetals such as
the heme centers in guanylate cyclase and cytochrome c oxidase [38].
It has been difﬁcult, therefore, to delineate the bioenergetic effects of
protein glutathiolation speciﬁcally over other thiol modiﬁcations. In
this study, we used diamide to titrate protein glutathiolation. The
utility of diamide, as opposed to other biochemical reagents or
reactive species, is that it reacts preferentially with small acidic thiols
(i.e., glutathione) and promotes predominantly the formation of
protein–glutathione mixed disulﬁdes (PSSG) [39]. To test these
concepts, we examined the effects of diamide on whole-cell
bioenergetic function using extracellular ﬂux analysis. This technol-
ogy allows for the concomitant measurement of glycolytic ﬂux and
mitochondrial oxygen consumption in real-time following a treat-
ment such as diamide.
We found that diamide dynamically modulates mitochondrial
function and glycolysis. At low concentrations, diamide modestly
increased glutathiolation and led to a robust augmentation of
mitochondrial proton leak and glycolytic ﬂux. At higher concentra-
tions, it promoted bioenergetic collapse associated with cell death,
both of which were fully reversible upon addition of a reducing agent.
Depletion of glutathione had no effect on basal protein thiolation or
cellular bioenergetic function. However, cells depleted of glutathione
that were treated with diamide formed less PSSG adducts at the
expense of increased protein–protein dithiol formation; these cells
were sensitized to diamide-induced bioenergetic dysfunction and
death. Glutathiolation may be a particularly important modiﬁcation
that regulates bioenergetic dysfunction in conditions associated with
oxidative stress.
2. Materials and methods
2.1. Materials
Diamide, antimycin A, carbonyl cyanide 4-(triﬂuoromethoxy)
phenylhydrazone (FCCP), oligomycin, sodium pyruvate, thiazoyl
blue tetrazolium, and buthionine sulfoximine (BSO) were purchased
from Sigma (St. Louis, MO). N-ethylmaleimide (NEM) and dithio-
threitol (DTT) were from Fisher Scientiﬁc (Pittsburgh, PA). Non-fat
dry blotting milk was from Biorad (Hercules, CA). Anti-protein–
glutathione antibody was from Virogen (Watertown, MA), and
horseradish peroxidase-linked anti-mouse secondary antibodies
were from Cell Signaling (Danvers, MA).
2.2. Cell culture and treatments
Rat aortic smooth muscle cells (RASMCs) were harvested from
descending thoracic aortas and maintained at 37 °C in 5% CO2 in
Dulbecco's Eagle Modiﬁed Medium (DMEM) growth medium (Invi-
trogen, Carlsbad, CA) containing 4mMGLUTAMAX, 5.5mM D-glucose,
1 mM pyruvate, 3.7 g/l sodium bicarbonate, 10% fetal bovine serum
(FBS, Atlanta Biologicals), 100 U/ml penicillin, and 100 ng/ml
streptomycin. Cells of passages 5–12 were used in this study.
Extracellular ﬂux, cell viability, and protein thiol modiﬁcation assays
were performed in unbuffered DMEM (Mediatech, Manassas, VA)
supplemented with 5.5 mM D-glucose, 4 mM glutamine, and 1 mMpyruvate. The pH of the medium was adjusted to 7.4 with NaOH
immediately prior to treatment. For cell treatments, diamide was
prepared as a 1 M stock solution in DMSO and diluted into assay
medium at 0–1 mM experimental concentrations. DMSO served as a
vehicle control in all experiments. For in situ reversibility experi-
ments, dithiothreitol (DTT; 1 mM) was added directly to cells treated
with vehicle or diamide for the indicated time. In some treatments,
buthionine sulfoximine (BSO) was used to deplete glutathione levels.
For these experiments, cells were seeded in 24-well plates at 30,000
cells per well and allowed to adhere overnight. The cells were then
treated with 0–1 mM BSO for 24 h prior to further treatments with
diamide and/or bioenergetic measurements.
2.3. Detection of protein–glutathione (PSSG) adducts
Protein glutathiolation was detected by Western blotting using
monoclonal anti-protein–glutathione (anti-PSSG) antibodies, essen-
tially as described [27], with minor modiﬁcations. Cells treated with
vehicle or diamide were lysed in buffer (pH 7.0) containing 20 mM
HEPES, 1 mM DTPA, 1% NP-40, 0.1% SDS, 25 mM N-ethylmaleimide
(NEM), and protease inhibitor cocktail. Proteins in the cell lysates
(10–15 μg) were added to Laemmli sample buffer containing 25 mM
NEM, separated by 10% SDS-PAGE, and transferred to PVDF mem-
branes at 40 V overnight or at 100 V for 2 h at 4 °C. The membranes
were washed brieﬂy in Tris-buffered saline containing 0.1% Tween-20
(TBS-tween) and then blocked in TBS-tween containing 5% milk and
2.5 mM NEM for 2 h at room temperature or overnight at 4 °C. In our
experience, inclusion of the NEM was critical for preserving PSSG
adducts and maximizing the signal on Western blots. After blocking,
membranes were washed in TBS-tween, and the membranes were
incubated for 2 h at room temperature or overnight at 4 °C with the
anti-PSSG antibody. Horseradish peroxidase-linked anti-mouse anti-
bodies were used as the secondary antibody. Immunoblots were
developedwith either ECL Plus chemiﬂuorescent reagent (Invitrogen)
or chemiluminescent Super Signal reagent (Pierce). The blots were
then imaged on either a Typhoon Variable Mode imager or on a
Fluorchem imager, respectively. Adduct signal was quantiﬁed by
densitometry.
2.4. Diagonal electrophoresis
Cells treated with DMSO or diamide (0.25 mM for 40 min) were
lysed in NEM-containing lysis buffer, and the proteins were separated
by SDS-PAGE as described above. After electrophoresis, the lanes were
excised and incubated in warm SDS running buffer (pH 8.3) contain-
ing 250 mM DTT for 30 min with constant agitation. The lanes were
then laid atop 12% SDS polyacrylamide resolving gels, overlaid with
agarose solution containing 100 mM DTT, and separated in the 2nd
dimension by electrophoresis. Proteins in the gels were stained using
Sypro Ruby and imaged on a Typhoon Variable Mode imager. Proteins
below the diagonal were used to assess the relative degree of protein–
protein disulﬁde formation.
2.5. Bioenergetic measurements
A Seahorse Bioscience XF24 Extracellular Flux Analyzer (North
Billerica, MA) was used to measure mitochondrial function in intact
RASMC. The XF24 creates a transient, 7 μl chamber in specialized
microplates that allows for the measurement of oxygen and proton
concentrations over time [40–42]. These measurements are then used
to determine mitochondrial oxygen consumption and glycolytic ﬂux
in several samples at once. To allow comparison between different
experiments, the data were expressed as the rate of oxygen
consumption (OCR) in pmol/min or the rate of extracellular
acidiﬁcation (ECAR) in mpH/min. In some experiments the data
were expressed as a percentage of the basal rate of OCR or ECAR. The
Fig. 1. Protein glutathiolation by diamide. Analysis of protein–glutathione (PSSG)
adduct formation by Western blotting: (A) Representative Western blot of PSSG
adducts. Cells were treated with diamide (0–1 mM) for 1 h. Cell lysate proteins were
then separated by SDS-PAGE followed by chemiﬂuorescent Western blotting using
anti-protein–glutathione (anti-PSSG) antibodies. (B) Group data from (A). N=3 per
group; ⁎pb0.05 vs. cells not treated with diamide.
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compounds of interest at any time during the assay measurements.
2.6. Glutathione measurements
RASMCs were seeded in Seahorse® 24-well plates at 40,000 cells
per well and allowed to adhere overnight. The cells were then treated
with 0–1mMBSO for 24 h. Total free glutathionewasmeasured by the
Tietze recycling assay, essentially as described [43], after lysing the
cells in 20 μl of lysis buffer containing phosphate-buffered saline, pH
7.4, 10 μM DTPA, and 0.1% Triton X-100. Total protein was measured
by the Bradford assay, and the glutathione content was normalized to
total protein.
2.7. Cell viability
Cell viability was measured by MTT assay as described previously
[44], with the following modiﬁcations. RASMCs were seeded as
described above into 24-well culture plates at 40,000 cells per well.
The cells were allowed to adhere overnight in complete medium. In
experiments employing the use of BSO, cells were initially seeded at
30,000 cells per well followed by treatment the following day with
BSO in complete medium. The cells were then treated in serum-free,
unbuffered DMEM with diamide or DTT, where indicated for 16 h in
the continued absence or presence of BSO. The medium was then
replaced with media containing 0.4 mg/ml thiazoyl blue tetrazolium.
The cells were then incubated at 37 °C for an additional 2 h. Themedia
was removed, and the resulting formazan crystals were solubilized in
250 μl DMSO. The absorbance was read at 550 nm and the data are
expressed as a percentage normalized to the average absorbance in
untreated cells.
2.8. Statistical analysis
Data are mean±standard error of measure (S.E.M.). Unpaired
Student's t-tests were used to compare groups. Statistical signiﬁcance
was accepted at pb0.05.
3. Results
3.1. Induction of protein glutathiolation by diamide
RASMCs were treated with 0–1 mM diamide for 60 min, and
proteins in the cell lysates were examined for PSSG adducts after
separation by SDS-PAGE. As shown in Fig. 1A and B, Western blot
analysis with anti-protein–glutathione (anti-PSSG) antibodies
showed a diamide concentration-dependent increase in PSSG adducts
that reached a maximal level with 0.5 mM diamide treatment.
3.2. Effect of protein thiolation on cellular bioenergetics
To determine whether the protein thiolation described in Fig. 1
affects cellular bioenergetics, cells were treated with diamide, and the
effects on oxygen consumption rate (OCR) and extracellular acidiﬁ-
cation rate (ECAR) were examined by extracellular ﬂux analysis. After
measurement of basal OCR and ECAR, diamide (0–1 mM) was
injected. As shown in Fig. 2A and B, diamide decreased OCR over
time in a concentration-dependent manner. The effects of diamide
treatment on glycolysis were also examined. Low concentrations of
diamide (100 μM) consistently increased ECAR to ≥200% of the
control level (Fig. 2C). Interestingly, higher concentrations of diamide
(e.g., 0.25 mM) caused an initial depression of ECAR followed by
recovery. As shown in Fig. 2D, higher concentrations of diamide
decreased ECAR below basal levels.
The bioenergetic changes in ECAR and OCR were then plotted
against one another at the ﬁnal time point indicated in Fig. 2A and C.This analysis yields a metabolic proﬁle of the cells after diamide
treatment at a deﬁned time of exposure. As shown in Fig. 2E, the
lowest concentration of diamide (0.1 mM) appeared to stimulate
glycolysis in the cell, i.e., it increased the glycolytic rate but did not
signiﬁcantly affect the consumption of oxygen at this time point.
However, higher concentrations of diamide (0.5–1.0 mM) resulted in
a less energetic cellular phenotype due to a decrease in both the
aerobic and glycolytic ﬂux in the cell.
3.3. Protein thiolation and mitochondrial function
To determine the effect of diamide on speciﬁc indices of
mitochondrial function, three basal oxygen consumption rates
(OCRs) were recorded, followed by the sequential injection of
oligomycin (1 μg/ml), FCCP (1 μM), and antimycin A (10 μM). OCR
measurements were recorded after each injection and used to
determine how intracellular mitochondria responded to treatment.
As shown in Fig. 3A, this assay was used to determine the level of
oxygen consumption related to ATP production and proton leak, i.e.,
the oligomycin-sensitive OCR was ascribed to oxygen consumption
linked to ATP production, and the oligomycin-insensitive OCR was
attributed to non-ATP-linked oxygen consumption, whichmay be due
to proton leak across the mitochondrial inner membrane. As shown in
Fig. 3A, the antimycin A-insensitive OCR was subtracted from the
basal rate and the oligomycin-insensitive rate to estimate the
mitochondrial contribution to these rates of oxygen consumption.
The FCCP-stimulated OCR was similarly used to calculate the maximal
Fig. 2. Bioenergetic changes induced by protein thiolation. Extracellular ﬂux analyses of diamide treated cells: Baseline measurements of (A) oxygen consumption rate (OCR) and (C)
extracellular acidiﬁcation rate (ECAR) were measured. Diamide was then injected where indicated to 0 (closed squares), 0.1 (diamonds; dashed line), 0.25 (open squares), 0.5
(triangles; dashed line), or 1.0 (circles; dotted line) mM ﬁnal concentrations. The OCR and ECAR expressed as a percentage of baseline are shown in (A) and (C). The changes in (B)
OCR and (D) ECAR at the last time point measured are shown as a function of diamide concentration. N=4 per group, ⁎pb0.05 vs. cells not treated with diamide. (E) Metabolic
proﬁle of diamide-treated cells: The last time points of OCR and ECAR measurements in (A) and (C), respectively, were used to construct a 2D plot of bioenergetic function. The
numbers next to each point indicate the concentration of diamide (in mM).
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calculated by subtracting the pre-oligomycin OCR from the FCCP-
stimulated OCR [45].
To examine the effect of protein thiolation on each of these indices
of mitochondrial function, diamide was injected after a basal OCR was
established. As shown in Fig. 3B, 0–0.5 mM diamide decreased the
OCR; however, as also shown in Fig. 2A, cells treated with 0.1 mM
diamide quickly recovered to their pre-diamide rate of oxygen
consumption. Sequential injection of oligomycin, FCCP, and antimycin
A then allowed for the determination of the effects of diamide on ATP-
linked OCR, proton leak, maximal respiratory capacity, and the
mitochondrial reserve capacity. As shown in Fig. 3C and D, oxygen
consumption in cells treated with vehicle was largely linked to ATP
production and proton leak was minimal. However, treatment of cells
with 0.1 mM diamide led to an approximately 6-fold increase in
proton leak and decreased ATP-linked oxygen consumption by N3-
fold. Nevertheless, at this concentration of diamide the response toFCCP was largely conserved and the cells retained a substantial
reserve capacity (Fig. 3B and E). Treatment of the cells with 0.25 or 0.5
mM diamide further increased the loss of ATP-linked OCR, led to less
of an increase in proton leak, and abrogated the maximal respiratory
capacity and the mitochondrial reserve capacity.
3.4. Effect of glutathione on mitochondrial function and cell viability
Because diamide increases protein-bound glutathione and
decreases free GSH levels [39,46], we tested whether the effects of
diamide on bioenergetics could simply be the indirect effects of GSH
depletion. Buthionine sulfoximine (BSO) was used to inhibit GSH
synthesis in RASMC. As shown in Fig. 4A, 50 μM BSO depleted GSH
maximally within a 24-h period and as shown in Fig. 4B, 0–0.5 mM
BSO treatment had no effect on ATP-linked oxygen consumption,
proton leak, maximal respiratory capacity, mitochondrial reserve
capacity, or the non-mitochondrial rates of oxygen consumption.
Fig. 3. Characterization of mitochondrial dysfunction induced by protein thiolation. Delineation of changes in ATP-linked oxygen consumption, proton leak, and respiratory capacity
in cells treated with diamide. (A) Extracellular ﬂux analysis was used to measure mitochondrial function in intact, adherent smooth muscle cells. To probe individual components of
respiration that contributed to the consumption of oxygen, oligomycin (1 μg/ml), FCCP (1 μM), and antimycin A (10 μM) were injected sequentially. This allowed for estimation of
the contribution of proton leak (Leak) and ATP demand (ATP) to mitochondrial oxygen consumption. The maximal respiratory capacity was determined using the FCCP-stimulated
rate. The residual oxygen consumption that occurred after addition of antimycin A was ascribed to non-mitochondrial sources. (B) After baseline measurements of oxygen
consumption rate (OCR), diamide was injected to 0 (closed squares), 0.1 (diamonds; dotted line), 0.25 (open squares), or 0.5 (triangles; dotted line) mM ﬁnal concentrations. At the
indicated time, oligomycin (O; 1 μg/ml) was injected and OCRwas measured. FCCP (F; 1 μM)was then injected followed by another OCR measurement. Last, antimycin A (A; 10 μM)
was injected and OCR was again measured. The oligomycin-sensitive and -insensitive rates of oxygen consumption were used to calculate the amount of oxygen consumption that
was linked to (C) ATP production and (D) proton leak. (E) The reserve or spare respiratory capacity was calculated in control and diamide-treated cells by subtracting the maximal
(FCCP-stimulated) rate of oxygen consumption from the basal OCR. N=5 per group, ⁎pb0.05 vs. cells not treated with diamide.
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However, GSH depletion sensitized cells to diamide-induced cell
death (Fig. 4D). These data suggest that protein thiolation reactions,
and not GSH depletion per se, are responsible for diamide-induced
changes in bioenergetics and cell viability.
3.5. Protein thiolation reactions in glutathione-depleted cells
To determine whether glutathione depletion affected PSSG adduct
formation, cells treated without and with BSO were exposed to
diamide for 40 min, and the glutathione adducts were examined by
Western blotting with anti-PSSG antibodies. As expected, GSH
depletion signiﬁcantly decreased protein glutathiolation by diamide
but had no effect on basal levels of GSH adducts (Fig. 5A and B).Diagonal electrophoresis was then used to determine whether
treatment with diamide also promoted protein–protein disulﬁde
formation. After treatment with 0.25 mM diamide, the cells were
collected in NEM-containing buffer and separated by SDS-PAGE. In the
2nd dimension, the proteins were reduced with DTT and again
separated by size. Protein signal below the diagonal therefore
represents proteins that were covalently disulﬁde-linked to another
protein. As shown in Fig. 5C, treatment of cells with 0.25 mM diamide
promoted little protein–protein thiolation compared to the large PSSG
adduct signal shown in Figs. 1A and 5A. These results are consistent
with the preference of diamide for oxidizing low molecular weight
thiols in preference to protein thiols and suggest that glutathiolation
was the predominant modiﬁcation occurring during diamide
treatment.
Fig. 4. Glutathione depletion does not affect mitochondrial function but potentiates diamide-induced cell death. (A) Cells were treated with buthionine sulfoximine (BSO; 0–1 mM)
for 24 h and free glutathione was measured by glutathione recycling assay. N≥3 per group, ⁎pb0.05 vs. cells not treated with BSO. (B) Mitochondrial function in glutathione-
depleted cells: Cells were treated with 0 (closed squares), 0.05 (open squares; dashed line), or 0.5 (open squares; dotted line) mM BSO for 24 h followed by mitochondrial function
assay. After three baseline measurements of oxygen consumption rate (OCR), oligomycin (O; 1 μg/ml), FCCP (F; 1 μM), and antimycin A (A; 10 μM) were injected sequentially, and
rates of oxygen consumption were recorded after each injection. (C) Glycolytic ﬂux in glutathione-depleted cells: After 24 h of 0 (closed squares), 0.05 (open squares; dashed line),
or 0.5 (open squares; dotted line) mM BSO treatment, baseline and oligomycin-stimulated extracellular acidiﬁcation rates (ECAR) were measured. Inset: At the point shown by the
arrow, the rate of extracellular was plotted for cells treated with 0–1 mM BSO. (D) Viability of normal (closed circles) and glutathione-depleted (open circles) cells treated with 0–
0.25 mM diamide. N≥3, and ⁎pb0.05 vs. diamide-treated cells not treated with BSO.
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in a smaller increase in glutathiolated proteins (Fig. 5A and B) and a
relatively larger increase in dithiol protein crosslinks (Fig. 5C, lower
right panel). BSO treatment alone had no effect on protein–protein
disulﬁde formation (Fig. 5C, lower left panel). These results show that
GSH levels regulate the degree to which proteins can be glutathiolated
in the cell under conditions of oxidant stress. Furthermore, the
relative increase in diamide-induced, protein–protein disulﬁdes
in glutathione-depleted cells was associated with a loss of viability
(Fig. 4D).3.6. Mitochondrial function in glutathione-depleted cells treated
with diamide
Mitochondrial function was also signiﬁcantly affected in glutathi-
one-depleted cells that were treated with diamide. As shown in
Fig. 6A, BSO treatment by itself had no effect on oxygen consumption;
however, diamide treatment of glutathione-depleted cells resulted
in a rapid decline in oxygen consumption. Although there was a
signiﬁcant decrease in oxygen consumption over a longer period of
time in cells treated with diamide only, these cells were attached and
still viable after 16 h as assessed by the MTT assay (Fig. 4D and data
not shown).
The glycolytic response of the cells to diamide was also signi-
ﬁcantly affected by glutathione depletion. As shown in Fig. 6B,
diamide by itself increased glycolytic ﬂux for the ﬁrst 150 min after
treatment and then decreased the ECAR to below control levels. In
BSO-treated cells, however, the cells demonstrated a much abbrevi-ated enhancement of ECAR followed by an abrupt decrease in
glycolytic ﬂux.
3.7. Reversibility of diamide-induced protein thiolation and
bioenergetic function
We next tested whether reduction of the protein thiol adducts
would result in recovery of bioenergetic function and cell viability. To
determine the degree of reversibility of the adducts, cells were treated
with 0.5mMdiamide for 40min followed by addition of 1mMDTT for
10 min. The cells were then lysed in NEM-containing buffer, and PSSG
adduct formationwas examined byWestern blotting. As shown in Fig.
7A and B, PSSG adducts formed upon diamide addition were
completely reduced after incubation of the cells with 1 mM DTT.
To determine if removal of adduct formation was sufﬁcient to
reverse the effect of diamide on bioenergetic function, cells were
treated with 0, 0.1, or 0.5 mM diamide for 40 min, and OCR was
monitored over time. DTTwas then injected to a ﬁnal concentration of
1 mM, and the OCR was examined. As shown in Fig. 7C, 0.1 mM
diamide had little effect on OCR in this time period, but 0.5 mM
diamide led to a collapse of mitochondrial function. DTT addition led
to a nearly instantaneous and complete recovery of the OCR. The effect
of diamide on glycolytic ﬂux was also reversed by DTT treatment.
Interestingly, the increase in ECAR by 0.1 mM diamide was more
slowly reversed by DTT treatment, and DTT treatment by itself had a
small but abbreviated effect on glycolytic ﬂux in the 0 and 0.5 mM
diamide treatment groups.
The effects of diamide on cell viability were also reversed by DTT
treatment. Cells were treated with 0–0.5 mM diamide in the absence
Fig. 5. Glutathione depletion decreases diamide-induced protein–glutathione adduct formation. Protein–glutathione adducts and protein–protein dithiol formation in glutathione-
depleted cells treated with diamide. (A) Protein–glutathione adducts in cells depleted of glutathione: Cells were treated with 100 μMBSO for 24 h followed by diamide (0–0.25 mM)
for 40 min. Equal amounts of protein (10 μg) from cell lysates were separated by SDS-PAGE, and glutathiolated proteins were detected by chemiﬂuorescent Western blotting with
anti-PSSG antibodies. (B) Group data from (A). N=3 per group; ⁎pb0.05 vs. glutathione-depleted cells treated with 0.1 mM diamide; #pb0.05 vs. glutathione-depleted cells treated
with 0.25 mM diamide. (C) Diagonal electrophoresis of proteins from control cells (upper left panel), cells treated with 0.25 mM diamide (upper right panel), glutathione-depleted
cells (lower left panel), and glutathione-depleted cells treated with 0.25 mM diamide. The arrow points to the area of the gel showing increased protein–protein dithiol formation.
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mM diamide were not viable after 16 h of treatment, and the presence
of DTT almost completely prevented death due to diamide as assessed
by MTT assay.
4. Discussion
Protein glutathiolation is an important post-translational protein
modiﬁcation that is increased under conditions of oxidative and
nitrosative stress. It regulates the function of a variety of enzymes and
is implicated in redox signaling, metabolic function, and apoptosis.
Nevertheless, an understanding of how glutathiolation itself mod-
ulates cell function has been difﬁcult to achieve. This is largely due to
themany types of oxidativemodiﬁcations induced by reactive species,
which confound our ability to discern the contribution of protein–
glutathione adducts to functional readouts. For instance, NO has been
shown to increase protein glutathiolation in a number of in vitro and
in vivo settings [27]; however, NO also interacts with metal centers in
proteins and can react with oxidants and amino acids [37,38]. In this
study, we examined how diamide modulates protein thiolation andcellular bioenergetics. There are several advantages to using diamide
for examining the overall impact of glutathiolation-induced changes
on bioenergetics. Reduced glutathione reacts rapidly with diamide,
with a rate constant of 300 M–1 s–1 at pH 7.3 [39]. Furthermore,
glutathione is 3–10 times more reactive with diamide compared with
other small thiols such as cysteine and lipoic acid [39]. Protein
glutathiolation by diamide proceeds via a sulfenylhydrazine interme-
diate during its reaction with GS– or protein thiolate anion (PS–) and
therefore yields the glutathiolating agent GSSG or PSSG directly
[39,47]. Oxygen is not required for diamide reactivity, and no radical
intermediates are involved in diamide-induced thiolation reactions
[39]. Therefore, the perturbation of thiol status in the cell by diamide
primarily involves the GSH/GSSG couple and the protein thiol redox
state, thereby minimizing subsidiary protein modiﬁcations.
We found that diamide promoted primarily protein–glutathione
adducts that were associated with robust effects on glycolysis,
mitochondrial function, and cell viability. Low levels of diamide did
not induce signiﬁcant toxicity, yet changed both glycolysis and
mitochondrial function; whereas higher levels of diamide caused
bioenergetic failure and cell death. In support of the hypothesis that
Fig. 6. Bioenergetic function in glutathione-depleted cells treated with diamide.
Extracellular ﬂux analysis plots of oxygen consumption and extracellular acidiﬁcation:
(A) Cells were treated without (closed squares) or with 100 μM BSO for 24 h (open
squares), and baseline oxygen consumption rates (OCR) were recorded. Diamide
(dotted lines) was then injected to a 0.1 mM ﬁnal concentration where indicated, and
the OCR were followed for approximately 300 min. (B) Glycolytic ﬂux in glutathione-
depleted cells treated with diamide: Cells were treated as described in (A) and rates of
extracellular acidiﬁcation were measured. N=5 per group.
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we found that: (a) depletion of intracellular GSH with BSO prevented
protein glutathiolation caused by diamide (Fig. 5); (b) GSH depletion
sensitized cells to diamide-induced bioenergetic collapse (Fig. 6) and
death (Fig. 4D); and (c) the thiol reducing agent DTT reversed the
metabolic effects and cell death caused by diamide while having no
signiﬁcant effects on control cells (Fig. 7). These data therefore appear
to rule out any non-speciﬁc effects of diamide (e.g., with reduced
pyridine nucleotides, etc. [48]). Collectively, these results point to a
role for thiolation reactions in themodulation of bioenergetic function
in the cell as well as suggest that protein glutathiolation at low levels
could be protective under conditions where thiol oxidation is
increased.
Mitochondria ﬁgure predominantly in bioenergetic function and
redox signaling. They are sites of reactive oxygen species generation
[49], and mitochondrial metabolic ﬂux can be controlled by NO
through its binding to cytochrome c oxidase [38]. Mitochondria are
also potential hotspots for oxidative post-translational protein
modiﬁcations. Several types of modiﬁcations have been shown to
occur on mitochondrial proteins, including, but not limited to, protein
sulfenic, sulﬁnic, and sulfonic acids [50,51], S-nitrosation [52,53], and
protein thiolation [20,26,27]. Of these, protein thiolation-type
modiﬁcations appear to be abundant, increased under conditions of
oxidative/nitrosative stress, and reversible, suggesting that they
could potentially regulate mitochondrial function. Nevertheless, it
has been difﬁcult to discern the whole-cell functional effects caused
by glutathiolation from those of other oxidative modiﬁcations.
In our treatments, protein–protein disulﬁde formation was
ancillary to protein glutathiolation. From diagonal electrophoresis
gels (Fig. 5), it was apparent that diamide induced comparativelylittle protein–protein thiol modiﬁcations compared to PSSG adducts.
The inhibitory effects of diamide on oxygen consumption and
glycolysis were maximal at 0.5 mM diamide. These changes were
fully reversible with DTT treatment; however, longer durations of
treatment with diamide (i.e., N60 min) resulted in less DTT
reversibility of the diamide-induced bioenergetic changes (data
not shown). Interestingly, lower concentrations of diamide (100
μM) had biphasic effects on glycolysis and oxygen consumption.
Diamide at this concentration consistently increased ECAR, suggest-
ing that it regulated glycolytic ﬂux. This may be due to either
modiﬁcation of enzymes that regulate glycolysis or a response to
loss of mitochondrial ATP production. Evidence for the former is
shown by several studies, where enzymes regulating glucose
utilization branch points are regulated by thiolation. For instance,
aldose reductase, which metabolizes glucose to sorbitol, has been
shown to be inactivated by glutathiolation [30,31]. Therefore,
glutathiolation may reroute carbohydrate ﬂux by regulating
enzymes controlling glucose metabolism pathways. Glyceralde-
hyde-3-phosphate dehydrogenase has also been shown to be
modiﬁed and inactivated by glutathiolation [5,28], and this may
underlie the loss of ECAR at higher concentrations or longer
exposures to diamide. The latter possibility, i.e., an increase in
glycolysis due to loss of respiratory activity, is supported by the fact
that diamide, even at low concentrations, decreased the apparent
oxygen consumption linked to ATP production and made oxygen
utilization less efﬁcient (Fig. 3). However, the changes in glycolysis
due to diamide exceeded the increase in ECAR due to oligomycin
treatment alone (see Fig. 4C), suggesting that loss of respiration
cannot be wholly responsible for increased glycolytic ﬂux during
diamide treatment.
Our studies support the notion that protein glutathiolation causes
mitochondrial uncoupling. It should be noted that the measurements
of proton leak described here are reﬂective of what occurs in state 4
respiration, i.e., the measurements were performed in the presence of
oligomycin; this is known to increase the mitochondrial membrane
potential, whichmaximizes changes in proton leak [54]. Nevertheless,
these measurements show that glutathiolation uncouples mitochon-
dria and decreases the capacity of the cell to utilize oxygen efﬁciently
for ATP production. This is consistent with a previous study showing
that diamide enhances proton conductivity through the Fo portion of
the mitochondrial ATPase [55]; however, it has also been shown in
submitochondrial particles that oligomycin inhibits this increase in
conductivity [56], suggesting that the diamide-induced proton leak
occurring in mitochondria in intact cells occurs via a different
mechanism. At higher concentrations, diamide decreased the FCCP-
stimulated rate of oxygen consumption and diminished the reserve
capacity (Fig. 3), consistent with inhibition of mitochondrial electron
transfer. Collectively, these results suggest that diamide, and therefore
protein thiolation, decreases mitochondrial efﬁciency and the bioen-
ergetic reserve capacity.
Interestingly, low concentrations of diamide had little effect on
cell viability. Diamide at the 0.1 mM concentration caused at most a
20% loss in cell viability (Fig. 7E). In most experiments, however, no
increase in cell death was observed after 16 h of treatment with this
concentration of diamide (Fig. 4D). However, 0.1 mM diamide
caused complete loss of viability in glutathione-depleted cells. This
is consistent with the hypothesis that glutathiolation, at low levels
such as that induced by 0.1 mM diamide (see Figs. 1 and 5), could
be protective under thiol-oxidizing conditions. For example, protein
glutathiolation, at low concentrations or when speciﬁcally regulated
by enzyme systems, could form a molecular cap that prevents other
deleterious modiﬁcations, e.g., protein–protein dithiol formation
[19]. Glutathione depletion, by itself, had no effect on cell viability
or basal mitochondrial function and little effect on glycolysis.
However, loss of glutathione due to BSO treatment decreased
protein glutathiolation due to diamide, and, under the same
Fig. 7. De-thiolation promotes bioenergetic recovery and prevents cell death. Protein–glutathione adducts, bioenergetics, and cell viability in diamide-treated cells exposed to the
reducing agent, dithiothreitol. (A) Dithiothreitol (DTT) reverses protein glutathiolation induced by diamide: Cells were treated without or with diamide for 40 min. DTT was then
added to the cells to a ﬁnal concentration of 1 mM for 10 min. The medium was then removed, and the cells were lysed in buffer containing N-ethylmaleimide. Protein–glutathione
(PSSG) adducts were assessed by chemiluminescent Western blotting with anti-PSSG antibodies. (B) Group data from (A). N=3 per group; ⁎pb0.05 vs. cells not treated with
diamide; #pb0.05 vs. diamide-treated cells not exposed to DTT. Bioenergetic measurements after diamide and DTT addition to cells: After measurement of the (C) baseline oxygen
consumption and (D) extracellular acidiﬁcation rates (OCR and ECAR, respectively), diamide was injected to 0 (closed squares), 0.1 (diamonds; dashed line), or 0.5 (circles; dotted
line) mM concentrations. At the indicated time, DTT was injected to a ﬁnal concentration of 1 mM, and OCR and ECAR measurements were recorded. N=5 per group. (E) Cell
viability in diamide and DTT-treated cells. Cells were treated with diamide in the absence or presence of 1 mMDTT for 16 h. Cell viability was thenmeasured byMTT assay. N=4 per
group; ⁎pb0.05 vs. cells treated with diamide alone.
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qualitatively by diagonal electrophoresis. These results support the
widely held view that glutathione levels regulate the degree of
protein glutathiolation that can be achieved in the cell under
conditions of oxidant stress.
The reversibility of the PSSG adducts with DTTwas associated with
a rapid restoration of oxygen consumption, normalization of glyco-
lytic ﬂux, and protection from cell death due to diamide treatment.
These ﬁndings are consistent with glutathiolation being a reversible
and regulated thiol modiﬁcation that controls cell function. Candidate
proteins that can enzymatically modulate PSSG adducts include the
thiolation/de-thiolation enzymes—glutaredoxin, sulﬁredoxin, PDI,
and GSTP [14,47]. An important limitation of these studies is that
they do not take into account such enzymatic control of glutathiola-tion, especially within deﬁned domains in the cell such as the
mitochondrion. Furthermore, it can be difﬁcult to relate the thiolation
reactions caused by diamide to those that could be caused by
endogenous or exogenous NO or ROS. However, many of the same
mitochondrial proteins or proteins involved in glucose metabolism
have been shown to be S-nitrosated [30,57], glutathiolated [4,27], and
S-oxidized [36,58], suggesting that S-nitrosated and sulfenic acid-
modiﬁed proteins could precede their glutathiolated forms.Moreover,
receptor agonists such as angiotensin II have been shown to promote
protein glutathiolation in smooth muscle cells [59], and TNF-α
promotes glutathiolation of GAPDH [60]. Our results indicate that
thiolation of these subproteomes could impact cellular bioenergetics
and that even small increases in protein thiolation can affect glycolysis
and aerobic respiration. Taken as a whole, glutathiolation appears to
294 B.G. Hill et al. / Biochimica et Biophysica Acta 1797 (2010) 285–295be an important modiﬁcation regulating bioenergetic function and
cell death. Interventions that modulate protein thiolation levels in
speciﬁc subdomains could therefore have therapeutic potential in
pathological conditions characterized by increased oxidative or
nitrosative stress.
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